ArticleClinicoEconomics and outcomes research : CEOR2020

Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis.

Courtney Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.